UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Activity and side effects of imatinib in patients with gastrointestinal stromal tumors: data from a German multicenter trial

European journal of medical research, 2011-05, Vol.16 (5), p.206-206

2011

Volltextzugriff (PDF)

Imatinib for hepatocellular cancer – Focus on pharmacokinetic/pharmacodynamic modelling and liver function

Cancer letters, 2008-02, Vol.260 (1), p.146-154

2008

Volltextzugriff (PDF)

Pharmacokinetic and Clinical Phase II Trial of Imatinib in Patients with Impaired Liver Function and Advanced Hepatocellular Carcinoma

Oncology, 2005-01, Vol.69 (5), p.363-371

2005

Volltextzugriff (PDF)

1805P Efficacy of olaparib (ola) + abiraterone (abi) vs placebo (pbo) + abi in the non-BRCA mutation (non-BRCAm) subgroup of patients (pts) with metastatic castration-resistant prostate cancer (mCPRC) in the PROpel trial

Annals of oncology, 2023-10, Vol.34, p.S975-S976

2023

Volltextzugriff (PDF)

2511 POSTER Imatinib plus hydroxyurea in pretreated non-progressive glioblastoma (GBM) – a single center phase II study

European journal of cancer supplements, 2007, Vol.5 (4), p.230-231

2007

Volltextzugriff (PDF)

Pulmonary neuroendocrine tumors: treatment need and new treatment options

Pneumologie (Stuttgart, Germany), 2011-03, Vol.65 (S 01)

2011

Volltextzugriff (PDF)

Single center phase II trial analysing the role of imatinib/hydroxyurea in patients (pts) with pretreated non-progressive glioblastoma (GBM) as maintenance treatment

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.2055-2055

2007

Volltextzugriff (PDF)

Multicenter, single-arm, two-stage phase II trial of everolimus (RAD001) with imatinib in imatinib-resistant patients (pts) with advanced GIST

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.10048-10048

2010

Volltextzugriff (PDF)

The tyrosine kinase inhibitor imatinib fails to inhibit pancreatic cancer progression

Cancer letters, 2006-02, Vol.233 (2), p.328-337

2006

Volltextzugriff (PDF)

Treatment failure due to intracerebral stem cell-like behavior of glioblastoma (GBM) cells: A reason for targeted maintenance therapy with imatinib (I) and hydroxyurea (H)? An analysis of study DE21 and DE40 (Ambrosia)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.2048-2048

2008

Volltextzugriff (PDF)

Imatinib plus hydroxyurea in pretreated non-progressive glioblastoma (GBM)—A single center phase II study

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.1583-1583

2006

Volltextzugriff (PDF)

Imatinib for hepatocellular cancer (HCC)—Focus on PK/PD modelling and liver function

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.13088-13088

2006

Volltextzugriff (PDF)

Therapie des fortgeschrittenen Pankreaskarzinoms mit dem Tyrosinkinasen-Inhibitor Glivec: Ergebnisse einer prospektiv, randomisierten klinischen Studie

Zeitschrift für Gastroenterologie, 2004, Vol.42 (8)

2004

Volltextzugriff (PDF)

Determination of soluble fibrin: A comparison of four different methods

Thrombosis research, 1992-03, Vol.65 (6), p.745-756

1992

Volltextzugriff (PDF)

Imatinib-Therapie bei Patienten mit hepatozellulärem Karzinom: Ergebnisse einer Phase-II-Studie

Zeitschrift für Gastroenterologie, 2004, Vol.42 (6)

2004

Volltextzugriff (PDF)

A prospective and randomised clinical trial of the tyrosine kinase inhibitor imatinib mesylate as an initial therapy of advanced pancreatic cancer

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.4151-4151

2004

Volltextzugriff (PDF)

A prospective and randomised clinical trial of the tyrosine kinase inhibitor imatinib mesylate as an initial therapy of advanced pancreatic cancer

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.4151-4151

2004

Volltextzugriff (PDF)

Pharmacokinetic (PK) and clinical phase II trial of imatinib in patients with impaired liver function and advanced hepatocellular carcinoma (HCC)

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.4135-4135

2005

Volltextzugriff (PDF)

Die literarische Stellung von Ausons Mosellied

Philologus, 1926-01, Vol.81, p.192

Hosius, C

1926

Volltextzugriff (PDF)

Getty, The lost of St. Gall Ms. of Valerius Flaccus (Book Review)

Gnomon, 1937, Vol.13, p.336

Hosius, C

1937

Volltextzugriff (PDF)

Helm, Die Praetexta Octavia (Book Review)

Gnomon, 1937, Vol.13, p.132

Hosius, C

1937

Volltextzugriff (PDF)

Rose, A Handbook of Latin Literature from the earliest times to the death of St. Augustine (Book Review)

Gnomon, 1937, Vol.13, p.492

Hosius, C

1937

Volltextzugriff (PDF)

The invective in Rufinum of Claudius Claudianus ed. Levy (Book Review)

Gnomon, 1937, Vol.13, p.222

Hosius, C

1937

Volltextzugriff (PDF)

1. Rutilius Namatianus ed. Helm. 2. Rutilius Namatianus. Texte établi et trad. par Vessereau et Préchac (Book Review)

Gnomon, 1934, Vol.10, p.542

Hosius, C

1934

Volltextzugriff (PDF)

Sénèque Des Bienfaits ed. Préchac (Book Review)

Gnomon, 1930, Vol.6, p.297

Hosius, C

1930

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(31)

Publikationsform

Sprache

Deutsch
(17)
Englisch
(16)
Latein
(1)

Erscheinungsjahr

n.n

Thema

Humans
(5)
Aged
(4)
Benzamides
(4)
Imatinib Mesylate
(4)
Life Sciences & Biomedicine
(4)
Middle Aged
(4)
Science & Technology
(4)
Adult
(3)
Female
(3)
Liver Neoplasms - Drug Therapy
(3)
Male
(3)
Oncology
(3)
Antineoplastic Agents - Therapeutic Use
(2)
Biological And Medical Sciences
(2)
Carcinoma, Hepatocellular - Drug Therapy
(2)
Chemotherapy
(2)
Drug Dosages
(2)
Hematology, Oncology And Palliative Medicine
(2)
Imatinib
(2)
Liver - Metabolism
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Activity and side effects of imatinib in patients with gastrointestinal stromal tumors: data from a German multicenter trial

Imatinib for hepatocellular cancer – Focus on pharmacokinetic/pharmacodynamic modelling and liver function

Pharmacokinetic and Clinical Phase II Trial of Imatinib in Patients with Impaired Liver Function and Advanced Hepatocellular Carcinoma

1805P Efficacy of olaparib (ola) + abiraterone (abi) vs placebo (pbo) + abi in the non-BRCA mutation (non-BRCAm) subgroup of patients (pts) with metastatic castration-resistant prostate cancer (mCPRC) in the PROpel trial

2511 POSTER Imatinib plus hydroxyurea in pretreated non-progressive glioblastoma (GBM) – a single center phase II study

Pulmonary neuroendocrine tumors: treatment need and new treatment options

Single center phase II trial analysing the role of imatinib/hydroxyurea in patients (pts) with pretreated non-progressive glioblastoma (GBM) as maintenance treatment

Multicenter, single-arm, two-stage phase II trial of everolimus (RAD001) with imatinib in imatinib-resistant patients (pts) with advanced GIST

The tyrosine kinase inhibitor imatinib fails to inhibit pancreatic cancer progression

Treatment failure due to intracerebral stem cell-like behavior of glioblastoma (GBM) cells: A reason for targeted maintenance therapy with imatinib (I) and hydroxyurea (H)? An analysis of study DE21 and DE40 (Ambrosia)

Imatinib plus hydroxyurea in pretreated non-progressive glioblastoma (GBM)—A single center phase II study

Imatinib for hepatocellular cancer (HCC)—Focus on PK/PD modelling and liver function

Therapie des fortgeschrittenen Pankreaskarzinoms mit dem Tyrosinkinasen-Inhibitor Glivec: Ergebnisse einer prospektiv, randomisierten klinischen Studie

Determination of soluble fibrin: A comparison of four different methods

Imatinib-Therapie bei Patienten mit hepatozellulärem Karzinom: Ergebnisse einer Phase-II-Studie

A prospective and randomised clinical trial of the tyrosine kinase inhibitor imatinib mesylate as an initial therapy of advanced pancreatic cancer

A prospective and randomised clinical trial of the tyrosine kinase inhibitor imatinib mesylate as an initial therapy of advanced pancreatic cancer

Pharmacokinetic (PK) and clinical phase II trial of imatinib in patients with impaired liver function and advanced hepatocellular carcinoma (HCC)

Die literarische Stellung von Ausons Mosellied

Getty, The lost of St. Gall Ms. of Valerius Flaccus (Book Review)

Helm, Die Praetexta Octavia (Book Review)

Rose, A Handbook of Latin Literature from the earliest times to the death of St. Augustine (Book Review)

The invective in Rufinum of Claudius Claudianus ed. Levy (Book Review)

1. Rutilius Namatianus ed. Helm. 2. Rutilius Namatianus. Texte établi et trad. par Vessereau et Préchac (Book Review)

Sénèque Des Bienfaits ed. Préchac (Book Review)

Suchergebnisse filtern